Republic Healthcare Ltd. has released its interim results for the six months ended 30 June 2025. The company reported a revenue of S$3.73 million, a decrease from S$4.48 million in the same period in 2024. The decline in revenue was observed across its medical services segment, including treatment services, medical investigation services, and consultation services. The company reported a net loss after tax of approximately S$1.20 million for the period, compared to a net loss of S$0.15 million in the corresponding period of the previous year. The widened loss was primarily attributed to increased expansion-related costs in the education business in the Philippines and a rise in manpower expenses linked to staff retention efforts. Republic Healthcare Ltd. has indicated that the global operating environment remains volatile due to ongoing geopolitical tensions and shifts in US foreign and trade policy. The company remains proactive in adapting to external conditions, strengthening operational efficiency, and exploring new revenue streams to position itself for long-term resilience. The Board of Directors has resolved not to declare the payment of a dividend for the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.